Trials / Conditions / Metastatic Breast Cancer ( HER2 Negative)
Metastatic Breast Cancer ( HER2 Negative)
4 registered clinical trials studyying Metastatic Breast Cancer ( HER2 Negative) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breas NCT07471776 | Fudan University | Phase 2 |
| Recruiting | Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer NCT07193394 | Institut Curie | Phase 2 |
| Recruiting | ctDNA-guided Treatment Decision-making NCT07394218 | Fudan University | Phase 2 |
| Completed | A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epid NCT01268150 | Eisai Inc. | Phase 2 |